A Two Week Double-Blind Placebo-Controlled Crossover Study To Compare The Efficacy And Safety Of A Pregabalin/PF-00489791 Combination Versus Pregabalin Alone In Patients With Post-Herpetic Neuralgia.
Phase of Trial: Phase II
Latest Information Update: 04 Mar 2009
At a glance
- Drugs PF 489791; Pregabalin
- Indications Postherpetic neuralgia
- Focus Therapeutic Use
- Sponsors Pfizer
- 05 Jan 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 05 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Apr 2008 Status changed from initiated to recruiting according to clinicaltrials.gov.